Pictet Asset Management Sa Pacira Bio Sciences, Inc. Transaction History

Pictet Asset Management Sa

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$35.53 - $43.38 $176,903 - $215,989	4,979 New	4,979 $203,000
Q2 2022 Aug 09, 2022	SELL	$51.49 - $81.64 $3.47 Million - $5.51 Million	-67,470 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$60.03 - $76.49 $42,201 - $53,772	-703 Reduced 1.03%	67,470 $5.15 Million
Q4 2021 Feb 10, 2022	SELL	$47.97 - $62.21 $382,656 - $496,249	-7,977 Reduced 10.48%	68,173 $4.1 Million
Q3 2021 Nov 12, 2021	BUY	$54.64 - $61.3 $4.16 Million - $4.67 Million	76,150 New	76,150 $4.26 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $870M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet Asset Management Sa with notifications on news.